An Impossible Balance: Antibiotic Resistance, Profits, and Public Health

DSpace/Manakin Repository

An Impossible Balance: Antibiotic Resistance, Profits, and Public Health

Citable link to this page

. . . . . .

Title: An Impossible Balance: Antibiotic Resistance, Profits, and Public Health
Author: Barella, Nigel
Citation: Nigel Barella, An Impossible Balance: Antibiotic Resistance, Profits, and Public Health (May 2011)
Full Text & Related Files:
Abstract: The scientific mechanism for the development of antibiotic resistance in microbes has long been understood, and has long cautioned against the use of low doses of antibiotics insufficient to treat disease thoroughly. Despite this, low doses of antibiotics have, for nearly half a century, been given to food animals to promote faster growth and greater feed efficiency. Though this raises public health concerns, a complex political landscape has historically prevented these public health concerns from dominating regulatory policy, and continues to do so. This paper examines the scientific, political, and legal issues associated with the use of antibiotics in animal agriculture, with particular focus on FDA’s historical and evolving role in regulating this issue, and concludes briefly with speculation about the future of this issue.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846728

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters